The largest database of trusted experimental protocols

11 protocols using sybr green premix reagent

1

Quantitative Analysis of miR-122 and pri-miR-122

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Real-time PCR analysis for miR-122 was performed using a TaqMan miRNA kit (Applied Biosystems, Foster City, CA, USA). The U6 endogenous control was used for normalization. miR-122 primary transcript (pri-miR-122) was detected using a high-capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA, USA) and a TaqMan pri-miRNA assay. Actin was used as an internal standard gene. Real-time fluorescence quantitative PCR was performed using SYBR green premix reagent (TaKaRa Bio Inc., Shiga, Japan). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal standard for quantification. Primers used in RT-PCR were chemically synthesized and are shown in Supplementary Table S1, S2 and S3. Relative expression was quantified using the comparative threshold cycle (CT) method.
+ Open protocol
+ Expand
2

Quantifying Total RNA using SYBR Green

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with Trizol Reagent and quantified by real-time PCR using the SYBR Green Premix Reagent (Takara Bio Inc., Shiga, Japan) with an internal control for normalization.
+ Open protocol
+ Expand
3

Quantitative Analysis of RNA Transcripts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with Trizol Reagent, and quantified by real-time PCR using the SYBR Green Premix Reagent (Takara Bio Inc., Shiga, Japan) with a GAPDH internal control for normalization. The following forward and reverse primers were used: human GAPDH forward, 5’-AGAAGGTGGTGAAGCAGGCGTCG-3’ and reverse, 5’-CCTTGGAGGCCATGTGGGCC-3’; cyclin G1 forward, 5’-AATGAAGGTACAGCCCAAGCA-3’ and reverse, 5’-GCTTTGACTTTCCAACACACC-3’; CAT-1 forward, 5’-CTTCATCACCGGCTGGAACT-3’ and reverse, 5’-GGGTCTGCCTATCAGCTCGT-3’; Bcl-w forward, 5’-GAGCCATATAGTTCCTTGGGA-3’ and reverse, 5’-TAGAATAAGTGGGGAGTGGGA-3’; PRKRA forward, 5’-ACGAATACGGCATGAAGACC-3’, and reverse, 5’-TGGAAGGGTCAGGCATTAAG-3’; NT5C3 forward, 5’-AAGAATGGCAGATGGAGTGG-3’ and reverse, 5’-ACAGTTCAATTGCACCCACA-3’; HBV pgRNA forward, 5’-TCTTGCCTTACTTTTGGAAG-3’ and reverse, 5’-AGTTCTTCTTCTAGGGGACC-3’; and total HBV RNA forward, 5’-CTCCCCGTCTGTGCCTTCTC-3’ and reverse, 5’-TCGGTCGTTGACATTGCTGA-3’.
+ Open protocol
+ Expand
4

RNA Extraction and RT-qPCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
TRIzol® reagent (Tiangen Biotech Co., Ltd., Beijing, China) was used to extract total RNA from cells. According to the manufacturer's protocols, 2 µg of RNA was used for cDNA synthesis using the First Strand cDNA Synthesis kit (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). RT-qPCR was performed using the SYBR Green Premix reagent (TakaraBio, Inc., Otsu, Japan) in an ABI 7500 Thermocycler (Thermo Fisher Scientific, Inc.). The PCR thermocycling conditions were as follows: Initial denaturation for 10 min at 95°C, 40 cycles of 95°C for 5 sec and 65°C for 31 sec, followed by 95°C for 15 sec, 60°C for 1 min, 95°C for 15 sec and a final extension at 72°C for 10 min and finally held at 4°C. β-actin was used as the internal control for normalization. The primers used for RT-qPCR were listed in Table I.
+ Open protocol
+ Expand
5

Quantifying HER2 and gp96 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with Trizol Reagent. Real-time PCR analysis for HER2 and gp96 mRNA levels was performed using the SYBR Green Premix Reagent (Takara Bio Inc., Shiga, Japan). A GAPDH endogenous control was used for normalization.
+ Open protocol
+ Expand
6

Quantitative RNA Expression Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with Trizol reagent and quantified using SYBR Green Premix Reagent (Takara Bio, Shiga, Japan) and a TaqMan miRNA kit (Applied Biosystems) according to the manufacturer’s protocols. The endogenous control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or U6 was used for normalization. The primers used are described in Table S8. Relative expression was quantified using the comparative threshold cycle (Ct) method.
+ Open protocol
+ Expand
7

Quantitative Real-Time PCR Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
The total RNA of cells was extracted using TRIZOL reagent and purified by 75% ethyl alcohol. Complementary DNA was synthesized using iscript reverse transcription kit (Takara) according to manufacturer’s instructions. Quantitative real-time PCR was performed with SYBR Green Premix reagent (Takara) on the 7300 real-time PCR system (ABI). Two-step PCR amplification standard procedure was used according to manufacturer’s instructions. The first stage: PCR was initiated at 95°C for 30 seconds to hot-start DNA polymerase and denature the template. The second stage (PCR reaction): 40 cycles that consisted of 95°C for 5 seconds, 60°C for 31 seconds. Data were calculated using the 2-ΔΔCt method. The primers used in the quantitative real-time PCR were synthesized in Life Technologies (S2 Table).
+ Open protocol
+ Expand
8

Quantification of Foxp3 mRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with Trizol reagent and quantified using real-time PCR using the SYBR Green Premix reagent (Takara Bio Inc., Shiga, Japan). The mRNA levels of Foxp3 were analyzed and normalized to Actb.
+ Open protocol
+ Expand
9

Quantifying HBV DNA Inhibition in HepG2.2.15 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HBV DNA was detected in HepG2.2.15 cells treated with IFN-α or TDS (0.8, 1.6 and 3.2 mg/ml) using quantitative PCR. Total DNA was extracted from the cell supernatant using the TIANamp Virus DNA/RNA kit (Tiangen Biotech Co., Ltd., Beijing, China) and Wizard® Genomic DNA Purification kit (Promega Corporation). The quantification of HBV DNA copies was performed using the SYBR green premix reagent (Takara Biotechnology Co., Ltd., Dalian, China). Total DNA (2 µg) was used as the template for each quantitative PCR assay. PCR was performed using an ABI 7900 real-time PCR detector (Applied Biosystems; Thermo Fisher Scientific, Inc.). The thermocycling conditions were as follows: 93°C for 2 min, 10 cycles at 93°C for 45 sec and 55°C for 60 sec, and 30 cycles at 93°C for 30 sec and 55°C for 45 sec. GAPDH served as a control gene. The primers utilized for HBV DNA fragment amplification were as follows: Forward primer, 5′-CCTCTTCATCCTGCTGCT-3′ and reverse primer, 5′-AACTGAAAGCCAAACAGTG-3′. GAPDH primers: Forward primer, 5′-CGGAGTCAACGGATTTGGTCGTAT-3′ and reverse primer, 5′-AGCCTTCTCCATGGTGGTGAAGAC-3′. Assays were repeated in triplicate and mean quantification cycle values were used to calculate the levels of HBV-DNA using the 2−ΔΔCq method (25 (link)). The inhibitory rate was calculated using the formula: Inhibitory rate (%)=[DNA copy (C) control-C sample]/C control ×100.
+ Open protocol
+ Expand
10

Quantification of RNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted with TRIzol Reagent (Waltham, MA, USA), mRNA levels were quantified by use of the SYBR Green Premix Reagent (Takara Bio Inc., Shiga, Japan), and microRNA levels were detected by use of a TaqMan microRNA kit (Applied Biosystems, Foster City, CA, USA) following the manufacturers’ protocols. The endogenous control glyceraldehyde-3-phosphate dehydrogenase (GAPDH) or U6 was used for normalization.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!